FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1975500416> ?p ?o ?g. }

• W1975500416 endingPage "2108" @default.
• W1975500416 startingPage "2081" @default.
• W1975500416 abstract "The delta(2)- 1,2,3- triazoline anticonvulsants (TRs) may be considered as representing a unique class of built-in heterocyclic prodrugs where the active structure element is an integral part of the ring system and can be identified only by a knowledge of their chemical reactivity and metabolism. Investigations on the metabolism and pharmacology of a lead triazoline, ADD17014 suggest that the triazolines function as prodrugs and exert their anticonvulsant activity by impairing excitatory amino acid (EAA) L-Glutamate (L-Glu) neurotransmission via a unique dual-action mechanism. While an active primary beta-amino alcohol metabolite from the parent prodrug acts as an N-methyl-D-aspartate (NMDA)/MK -801 receptor antagonist, the parent triazoline impairs the presynaptic release of L-Glu. Various pieces of theoretical reasoning and experimental evidence have led to the clucidation of the dual-action mechanism. Based on the unique chemistry of the triazolines, and their metabolic pathways, biotransformation products of TRs were predicted to be the beta-amino alcohols V and VA, the alpha-amino acid VI, the triazole VII, the aziridine VIII and the ketimine IX. In vivo and in vitro pharmacological studies of the TR and potential metabolites, along with a full quantitative urinary metabolic profiling of TR indicated the primary beta-amino alcohol V as the active species. It was the only compound that inhibited the specific binding of [3H]MK-801 to the MK-801 site, 56% at 10 micro M drug concentration, but itself had no anticonvulsant activity, suggesting TR acted as a prodrug. Three metabolites were identified; V was the most predominant (45.7 +/- 7.6) % of administered drug, with lesser amounts of VA, (17.3 +/- 5.1) % and very minor amounts of aziridine VIII (4.0 +/- 0.02)%. Since only VIII can yield VA, its formation indicated that the biotransformation of TR occurred, at least in part, through aziridine. No amino acid metabolite was detected, which implied that no in vivo oxidation of V or oxidative biotransformation of TR or aziridine by hydroxylation at the methylene group occurred. While triazoline significantly decreased Ca(2+) -dependent, k(+)-evoked L-Glu release (83% at 100 micro M drug concentration ), some triazolines showed an augmentation of 50-63%, in the Cl(-) channel activity, a useful membrane action that reduces the excessive L-Glu release that occurs during epileptic seizures. The high anticonvulsant activity of TRs in a variety of seizure models including their effectiveness in the kindling model of complex partial seizures may be due to their unique dual-action mechanism whereby the TR and V together effectively impair both pre- and postsynaptic aspects of EAA neurotransmission; thus the TRs have clinical potential in the treatment of complex partial epilepsy which is refractory to currently available drugs. Since there is strong evidence that L-Glu plays an important role in human epilepsy as well as in brain ischemia/stroke, and since the TRs act by inhibiting EAA neurotransmission, it was logical to expect that the anticonvulsant TRs may evince beneficial therapeutic potential in cerebral ischemia resulting from stroke as well. And indeed, several TRs, when tested in the standard gerbil model of global ischemia did evince remarkable ability to prevent neuronal death." @default.
• W1975500416 created "2016-06-24" @default.
• W1975500416 creator A5019440974 @default.
• W1975500416 date "2003-10-01" @default.
• W1975500416 modified "2023-10-16" @default.
• W1975500416 title "Rational Drug Design and the Discovery of the Δ2-1,2,3-Triazolines, A Unique Class of Anticonvulsant and Antiischemic Agents" @default.
• W1975500416 doi "https://doi.org/10.2174/0929867033456765" @default.
• W1975500416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12871087" @default.
• W1975500416 hasPublicationYear "2003" @default.
• W1975500416 type Work @default.
• W1975500416 sameAs 1975500416 @default.
• W1975500416 citedByCount "16" @default.
• W1975500416 countsByYear W19755004162012 @default.
• W1975500416 countsByYear W19755004162013 @default.
• W1975500416 countsByYear W19755004162017 @default.
• W1975500416 countsByYear W19755004162018 @default.
• W1975500416 countsByYear W19755004162019 @default.
• W1975500416 countsByYear W19755004162021 @default.
• W1975500416 crossrefType "journal-article" @default.
• W1975500416 hasAuthorship W1975500416A5019440974 @default.
• W1975500416 hasConcept C108215921 @default.
• W1975500416 hasConcept C149151106 @default.
• W1975500416 hasConcept C185592680 @default.
• W1975500416 hasConcept C202751555 @default.
• W1975500416 hasConcept C2776120743 @default.
• W1975500416 hasConcept C2777477808 @default.
• W1975500416 hasConcept C55493867 @default.
• W1975500416 hasConcept C71240020 @default.
• W1975500416 hasConcept C71924100 @default.
• W1975500416 hasConcept C98274493 @default.
• W1975500416 hasConceptScore W1975500416C108215921 @default.
• W1975500416 hasConceptScore W1975500416C149151106 @default.
• W1975500416 hasConceptScore W1975500416C185592680 @default.
• W1975500416 hasConceptScore W1975500416C202751555 @default.
• W1975500416 hasConceptScore W1975500416C2776120743 @default.
• W1975500416 hasConceptScore W1975500416C2777477808 @default.
• W1975500416 hasConceptScore W1975500416C55493867 @default.
• W1975500416 hasConceptScore W1975500416C71240020 @default.
• W1975500416 hasConceptScore W1975500416C71924100 @default.
• W1975500416 hasConceptScore W1975500416C98274493 @default.
• W1975500416 hasIssue "20" @default.
• W1975500416 hasLocation W19755004161 @default.
• W1975500416 hasLocation W19755004162 @default.
• W1975500416 hasOpenAccess W1975500416 @default.
• W1975500416 hasPrimaryLocation W19755004161 @default.
• W1975500416 hasRelatedWork W1536088879 @default.
• W1975500416 hasRelatedWork W2035115059 @default.
• W1975500416 hasRelatedWork W2044607430 @default.
• W1975500416 hasRelatedWork W2057787401 @default.
• W1975500416 hasRelatedWork W2072172265 @default.
• W1975500416 hasRelatedWork W2100740897 @default.
• W1975500416 hasRelatedWork W2114321573 @default.
• W1975500416 hasRelatedWork W2142346783 @default.
• W1975500416 hasRelatedWork W2395837122 @default.
• W1975500416 hasRelatedWork W2582322678 @default.
• W1975500416 hasVolume "10" @default.
• W1975500416 isParatext "false" @default.
• W1975500416 isRetracted "false" @default.
• W1975500416 magId "1975500416" @default.
• W1975500416 workType "article" @default.